What is the price target for PSTI stock?
8 analysts have analysed PSTI and the average price target is 3.57 USD. This implies a price increase of 257% is expected in the next year compared to the current price of 1.
PLURISTEM THERAPEUTICS INC (PSTI) Forecast, Price Target & Analyst Ratings
NASDAQ:PSTI • US72940R3003
Current stock price
1 USD
-0.03 (-2.91%)
At close:
1.03 USD
+0.03 (+3%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PLURISTEM THERAPEUTICS INC (PSTI).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q4 / 2022
- EPS Estimate
- -$0.33
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$3.57
Upside
+ 257.00%
From current price of $1.00 to mean target of $3.57, Based on 8 analyst forecasts
Low
$3.03
Median
$3.57
High
$4.20
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for PSTI. The average price target is 3.57 USD. This implies a price increase of 257% is expected in the next year compared to the current price of 1.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.50%
PSTI was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about PSTI.
In the previous month the buy percentage consensus was at a similar level.
PSTI was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-07-20 | Alliance Global Partners | Maintains | Buy |
| 2021-05-04 | Alliance Global Partners | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q4 / 2022
- EPS Estimate
- -$0.33
- Revenue Estimate
- N/A
- Revenue Q2Q
- N/A
- EPS Q2Q
- 29.04%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 50K | 50K | 20K -60.00% | -100.00% | 32.963M | 57.825M 75.43% | 99.452M 71.99% | 174.464M 75.43% | ||
| EBITDA YoY % growth | -31.71M -22.72% | -33.57M -5.87% | -27.91M 16.86% | N/A 286.28% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -33.73M -20.38% | -35.53M -5.34% | -29.48M 17.03% | -44.418M 271.71% | -42.33M -183.62% | -46.532M -9.93% | -3.389M 92.72% | -4.698M -38.62% | -6.642M -41.39% | |
| Operating Margin | -67,460.00% | -71,060.00% | -147,400.00% | N/A | N/A | -141.17% | -5.86% | -4.72% | -3.81% | |
| EPS YoY % growth | -2.60 18.75% | -3.03 -16.54% | -1.60 47.19% | -1.69 -10.00% | -1.04 40.89% | -1.68 -61.76% | -0.05 96.97% | -0.06 -15.30% | -0.07 -17.60% |
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 22 | Q1 / 23 | Q2 / 23 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.33 29.04% | -0.31 15.00% | -0.32 7.00% |
| Revenue Q2Q % growth | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A |
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.38%
EPS Next 5 Year
14.41%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
PLURISTEM THERAPEUTICS INC / PSTI Forecast FAQ
How many analysts cover PLURISTEM THERAPEUTICS INC (PSTI) stock?
The number of analysts covering PLURISTEM THERAPEUTICS INC (PSTI) is 8.